Antidepressant Treatment in Chronic Central Serous Chorioretinopathy: Case Series

Turkoglu C.

Journal of the College of Physicians and Surgeons Pakistan, vol.35, no.1, pp.54-56, 2025 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 1
  • Publication Date: 2025
  • Doi Number: 10.29271/jcpspcr.2025.54
  • Journal Name: Journal of the College of Physicians and Surgeons Pakistan
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.54-56
  • Keywords: Central serous chorioretinopathy, Choroid, Depression, Escitalopram, Visual acuity
  • Lokman Hekim University Affiliated: Yes

Abstract

The study investigated chronic central serous chorioretinopathy (CSCR) patients who were observed and treated between February 2023 and 2024. It is a prospective, observational case series. Three patients diagnosed with chronic CSCR, aged between 38 and 64 years, were included in the study. One (33.3%) of the patients was female and two (66.7%) were males. The patients were followed with Optical Coherence Tomography (OCT) and OCT angiography for 12 months under oral escitalopram 10 mg treatment. Following the treatment, both anatomical improvement and visual acuity increase were detected in all patients. In addition to the advantage of being noninvasive, oral escitalopram treatment appears to contribute quickly and effectively to anatomical and functional recovery.